Blackstone to sell Japan’s Alinamin to MBK for $2.2bn

Blackstone to sell Japan’s Alinamin to MBK for $2.2bn

Private equity firm Blackstone is nearing a deal to sell Japanese supplement maker Alinamin Pharmaceutical to North Asian buyout fund MBK Partners for $2.17bn.The deal is expected to be signed soon, said the person, who declined to be identified as the information was...